Transfection of HCC cells with the RASSF1A gene using Gal-CMCS-Fe3O4-NPs inhibited the growth of tumors and increased the sensitivity of HCC cells to chemotherapy, suggesting the importance of RASSF1A for HCC gene therapy. Here, RASSF1 is linked to hepatocellular carcinoma.